Peloton Wealth Strategists’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.54M | Sell |
13,680
-1,700
| -11% | -$316K | 1.02% | 37 |
|
2025
Q1 | $3.22M | Sell |
15,380
-7,000
| -31% | -$1.47M | 1.35% | 27 |
|
2024
Q4 | $3.98M | Sell |
22,380
-35
| -0.2% | -$6.22K | 1.6% | 22 |
|
2024
Q3 | $4.43M | Sell |
22,415
-2,285
| -9% | -$451K | 1.76% | 18 |
|
2024
Q2 | $4.24M | Sell |
24,700
-135
| -0.5% | -$23.2K | 1.74% | 20 |
|
2024
Q1 | $4.52M | Sell |
24,835
-170
| -0.7% | -$31K | 1.84% | 18 |
|
2023
Q4 | $3.88M | Sell |
25,005
-2,090
| -8% | -$324K | 1.68% | 23 |
|
2023
Q3 | $4.04M | Sell |
27,095
-14,380
| -35% | -$2.14M | 1.86% | 20 |
|
2023
Q2 | $5.59M | Sell |
41,475
-2,150
| -5% | -$290K | 2.47% | 10 |
|
2023
Q1 | $6.95M | Sell |
43,625
-80
| -0.2% | -$12.8K | 3.18% | 3 |
|
2022
Q4 | $7.06M | Sell |
43,705
-1,600
| -4% | -$259K | 3.4% | 3 |
|
2022
Q3 | $6.08M | Sell |
45,305
-65
| -0.1% | -$8.72K | 3.16% | 2 |
|
2022
Q2 | $6.95M | Sell |
45,370
-2,759
| -6% | -$423K | 3.39% | 2 |
|
2022
Q1 | $7.8M | Sell |
48,129
-380
| -0.8% | -$61.6K | 3.26% | 4 |
|
2021
Q4 | $6.57M | Sell |
48,509
-580
| -1% | -$78.5K | 2.63% | 5 |
|
2021
Q3 | $5.3M | Sell |
49,089
-1,960
| -4% | -$211K | 2.17% | 16 |
|
2021
Q2 | $5.75M | Buy |
51,049
+3,200
| +7% | +$360K | 2.37% | 12 |
|
2021
Q1 | $5.18M | Buy |
47,849
+1,176
| +3% | +$127K | 2.43% | 13 |
|
2020
Q4 | $5M | Buy |
46,673
+700
| +2% | +$75K | 2.48% | 13 |
|
2020
Q3 | $4.03M | Buy |
45,973
+1,510
| +3% | +$132K | 2.26% | 14 |
|
2020
Q2 | $4.37M | Buy |
44,463
+18,483
| +71% | +$1.81M | 2.75% | 7 |
|
2020
Q1 | $1.98M | Buy |
25,980
+9,268
| +55% | +$706K | 1.61% | 27 |
|
2019
Q4 | $1.48M | Buy |
16,712
+1,150
| +7% | +$102K | 0.9% | 45 |
|
2019
Q3 | $1.18M | Buy |
+15,562
| New | +$1.18M | 0.75% | 51 |
|